Corton Capital Inc. Cor Medix Inc. Transaction History
Corton Capital Inc.
- $38.2 Million
- Q3 2025
A detailed history of Corton Capital Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 19,667 shares of CRMD stock, worth $223,023. This represents 0.62% of its overall portfolio holdings.
Number of Shares
19,667
Previous 11,041
78.13%
Holding current value
$223,023
Previous $136,000
72.79%
% of portfolio
0.62%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
207Shares Held
41.5MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...